Correlation Between Eupraxia Pharmaceuticals and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals and Inhibrx, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Inhibrx.
Diversification Opportunities for Eupraxia Pharmaceuticals and Inhibrx
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eupraxia and Inhibrx is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Inhibrx go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Inhibrx
Assuming the 90 days horizon Eupraxia Pharmaceuticals is expected to under-perform the Inhibrx. In addition to that, Eupraxia Pharmaceuticals is 1.01 times more volatile than Inhibrx. It trades about -0.14 of its total potential returns per unit of risk. Inhibrx is currently generating about -0.05 per unit of volatility. If you would invest 3,740 in Inhibrx on November 5, 2024 and sell it today you would lose (2,468) from holding Inhibrx or give up 65.99% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 32.93% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals vs. Inhibrx
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Inhibrx |
Eupraxia Pharmaceuticals and Inhibrx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Inhibrx
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Inhibrx |
| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |